These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 24051221)
1. p-21-Activated kinase-1, -4 and -6 and estrogen receptor expression pattern in normal placenta and gestational trophoblastic diseases. Shoni M; Nagymanyoki Z; Vitonis AF; Jimenez C; Ng SW; Quade BJ; Berkowitz RS Gynecol Oncol; 2013 Dec; 131(3):759-63. PubMed ID: 24051221 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381 [TBL] [Abstract][Full Text] [Related]
3. Expression of maspin in gestational trophoblastic disease. Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230 [TBL] [Abstract][Full Text] [Related]
5. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors. Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Shih IM; Kurman RJ Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672 [TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathological parameters. Xue WC; Khoo US; Ngan HY; Chan KY; Chiu PM; Tsao SW; Cheung AN Histopathology; 2003 Nov; 43(5):485-90. PubMed ID: 14636275 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta. Singh M; Kindelberger D; Nagymanyoki Z; Ng SW; Quick CM; Yamamoto H; Fichorova R; Fulop V; Berkowitz RS J Reprod Med; 2012; 57(5-6):197-203. PubMed ID: 22696812 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Chilosi M; Piazzola E; Lestani M; Benedetti A; Guasparri I; Granchelli G; Aldovini D; Leonardi E; Pizzolo G; Doglioni C; Menestrina F; Mariuzzi GM Lab Invest; 1998 Mar; 78(3):269-76. PubMed ID: 9520940 [TBL] [Abstract][Full Text] [Related]
10. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics. Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816 [TBL] [Abstract][Full Text] [Related]
11. Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease. Somers GR; Bradbury R; Trute L; Conigrave A; Venter DJ Lab Invest; 1999 Feb; 79(2):131-9. PubMed ID: 10068202 [TBL] [Abstract][Full Text] [Related]
12. Differential expression patterns of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) -1, -4, -5, and -14 in human placenta and gestational trophoblastic diseases. Lee SY; Lee HS; Gil M; Kim CJ; Lee YH; Kim KR; Park CS Arch Pathol Lab Med; 2014 May; 138(5):643-50. PubMed ID: 24786121 [TBL] [Abstract][Full Text] [Related]
14. p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease. Siu MK; Yeung MC; Zhang H; Kong DS; Ho JW; Ngan HY; Chan DC; Cheung AN Am J Pathol; 2010 Jun; 176(6):3015-22. PubMed ID: 20413688 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and their inhibitors and inducer in gestational trophoblastic diseases and normal placenta. Singh M; Kindelberger D; Nagymanyoki Z; Ng SW; Quick CM; Elias KM; Yamamoto H; Fichorova R; Fulop V; Berkowitz RS Gynecol Oncol; 2011 Jul; 122(1):178-82. PubMed ID: 21514631 [TBL] [Abstract][Full Text] [Related]
16. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions. Xue WC; Khoo US; Ngan HY; Chan KY; Ip PP; Tsao SW; Cheung AN Int J Gynecol Pathol; 2004 Apr; 23(2):145-50. PubMed ID: 15084843 [TBL] [Abstract][Full Text] [Related]
17. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871 [TBL] [Abstract][Full Text] [Related]
18. PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases. Veras E; Kurman RJ; Wang TL; Shih IM Int J Gynecol Pathol; 2017 Mar; 36(2):146-153. PubMed ID: 27362903 [TBL] [Abstract][Full Text] [Related]
19. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635 [TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]